RTOG 0614 - A Randomized, Phase III, Double-Blind, Placebo-Controlled Trial of Memantine for Prevention of Cognitive Dysfunction in Patients Receiving Whole-Brain Radiotherapy.

Clinical Trial Categories

• Brain Cancer

Contact

The Rosenfeld Cancer Center at 215-481-2402